<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38534740</PMID><DateRevised><Year>2024</Year><Month>03</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1467-3045</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>29</Day></PubDate></JournalIssue><Title>Current issues in molecular biology</Title><ISOAbbreviation>Curr Issues Mol Biol</ISOAbbreviation></Journal><ArticleTitle>COVID-19 Associated Cardiovascular Disease-Risks, Prevention and Management: Heart at Risk Due to COVID-19.</ArticleTitle><Pagination><StartPage>1904</StartPage><EndPage>1920</EndPage><MedlinePgn>1904-1920</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3390/cimb46030124</ELocationID><Abstract><AbstractText>The SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) virus and the resulting COVID-19 pandemic have had devastating and lasting impact on the global population. Although the main target of the disease is the respiratory tract, clinical outcomes, and research have also shown significant effects of infection on other organ systems. Of interest in this review is the effect of the virus on the cardiovascular system. Complications, including hyperinflammatory syndrome, myocarditis, and cardiac failure, have been documented in the context of COVID-19 infection. These complications ultimately contribute to worse patient outcomes, especially in patients with pre-existing conditions such as hypertension, diabetes, or cardiovascular disease (CVD). Importantly and interestingly, reports have demonstrated that COVID-19 also causes myocardial injury in adults without pre-existing conditions and contributes to systemic complications in pediatric populations, such as the development of multisystem inflammatory syndrome in children (MIS-C). Although there is still a debate over the exact mechanisms by which such complications arise, understanding the potential paths by which the virus can influence the cardiovascular system to create an inflammatory environment may clarify how SARS-CoV-2 interacts with human physiology. In addition to describing the mechanisms of disease propagation and patient presentation, this review discusses the diagnostic findings and treatment strategies and the evolution of management for patients presenting with cardiovascular complications, focusing on disease treatment and prevention.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kemerley</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><Identifier Source="ORCID">0009-0007-0964-8339</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Molecular Cardiology and Angiogenesis Laboratory, University of Connecticut School of Medicine, UConn Health, 263 Farmington Avenue, Farmington, CT 06030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Abhishek</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery, Molecular Cardiology and Angiogenesis Laboratory, University of Connecticut School of Medicine, UConn Health, 263 Farmington Avenue, Farmington, CT 06030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thirunavukkarasu</LastName><ForeName>Mahesh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery, Molecular Cardiology and Angiogenesis Laboratory, University of Connecticut School of Medicine, UConn Health, 263 Farmington Avenue, Farmington, CT 06030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maloney</LastName><ForeName>Monica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery, Molecular Cardiology and Angiogenesis Laboratory, University of Connecticut School of Medicine, UConn Health, 263 Farmington Avenue, Farmington, CT 06030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burgwardt</LastName><ForeName>Sean</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, Molecular Cardiology and Angiogenesis Laboratory, University of Connecticut School of Medicine, UConn Health, 263 Farmington Avenue, Farmington, CT 06030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maulik</LastName><ForeName>Nilanjana</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-1585-1783</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Molecular Cardiology and Angiogenesis Laboratory, University of Connecticut School of Medicine, UConn Health, 263 Farmington Avenue, Farmington, CT 06030, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Curr Issues Mol Biol</MedlineTA><NlmUniqueID>100931761</NlmUniqueID><ISSNLinking>1467-3037</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACE2</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">cytokines</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">myocardium</Keyword><Keyword MajorTopicYN="N">pneumonia</Keyword><Keyword MajorTopicYN="N">spike protein</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>27</Day><Hour>12</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>27</Day><Hour>12</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>27</Day><Hour>9</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38534740</ArticleId><ArticleId IdType="pmc">PMC10969474</ArticleId><ArticleId IdType="doi">10.3390/cimb46030124</ArticleId><ArticleId IdType="pii">cimb46030124</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO . WHO Coronavirus (COVID-19) Dashboard|WHO Coronavirus (COVID-19) Dashboard with Vaccination Data. WHO; Geneva, Switzerland: 2023.</Citation></Reference><Reference><Citation>Liu F., Liu F., Wang L. COVID-19 and cardiovascular diseases. J. Mol. Cell Biol. 2021;13:161&#x2013;167. doi: 10.1093/jmcb/mjaa064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jmcb/mjaa064</ArticleId><ArticleId IdType="pmc">PMC7717280</ArticleId><ArticleId IdType="pubmed">33226078</ArticleId></ArticleIdList></Reference><Reference><Citation>Tersalvi G., Vicenzi M., Calabretta D., Biasco L., Pedrazzini G., Winterton D. Elevated Troponin in Patients with Coronavirus Disease 2019: Possible Mechanisms. J. Card. Fail. 2020;26:470&#x2013;475. doi: 10.1016/j.cardfail.2020.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cardfail.2020.04.009</ArticleId><ArticleId IdType="pmc">PMC7166030</ArticleId><ArticleId IdType="pubmed">32315733</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonow R.O., O&#x2019;Gara P.T., Yancy C.W. Cardiology and COVID-19. JAMA. 2020;324:1131&#x2013;1132. doi: 10.1001/jama.2020.15088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.15088</ArticleId><ArticleId IdType="pubmed">32960249</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo T., Fan Y., Chen M., Wu X., Zhang L., He T., Wang H., Wan J., Wang X., Lu Z. Cardiovascular Implications of Fatal Outcomes of Patients with Coronavirus Disease 2019 (COVID-19) JAMA Cardiol. 2020;5:811&#x2013;818. doi: 10.1001/jamacardio.2020.1017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1017</ArticleId><ArticleId IdType="pmc">PMC7101506</ArticleId><ArticleId IdType="pubmed">32219356</ArticleId></ArticleIdList></Reference><Reference><Citation>Bangalore S., Sharma A., Slotwiner A., Yatskar L., Harari R., Shah B., Ibrahim H., Friedman G.H., Thompson C., Alviar C.L., et al. ST-Segment Elevation in Patients with COVID-19&#x2014;A Case Series. N. Engl. J. Med. 2020;382:2478&#x2013;2480. doi: 10.1056/NEJMc2009020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2009020</ArticleId><ArticleId IdType="pmc">PMC7182015</ArticleId><ArticleId IdType="pubmed">32302081</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong E., Du H., Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. Dis. 2020;20:533&#x2013;534. doi: 10.1016/S1473-3099(20)30120-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30120-1</ArticleId><ArticleId IdType="pmc">PMC7159018</ArticleId><ArticleId IdType="pubmed">32087114</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung M.K., Zidar D.A., Bristow M.R., Cameron S.J., Chan T., Harding C.V., 3rd, Kwon D.H., Singh T., Tilton J.C., Tsai E.J., et al. COVID-19 and Cardiovascular Disease: From Bench to Bedside. Circ. Res. 2021;128:1214&#x2013;1236. doi: 10.1161/CIRCRESAHA.121.317997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.317997</ArticleId><ArticleId IdType="pmc">PMC8048382</ArticleId><ArticleId IdType="pubmed">33856918</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y., Yang H., Ji W., Wu W., Chen S., Zhang W., Duan G. Virology, Epidemiology, Pathogenesis, and Control of COVID-19. Viruses. 2020;12:372. doi: 10.3390/v12040372.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12040372</ArticleId><ArticleId IdType="pmc">PMC7232198</ArticleId><ArticleId IdType="pubmed">32230900</ArticleId></ArticleIdList></Reference><Reference><Citation>Alpert T., Brito A.F., Lasek-Nesselquist E., Rothman J., Valesano A.L., MacKay M.J., Petrone M.E., Breban M.I., Watkins A.E., Vogels C.B.F., et al. Early introductions and community transmission of SARS-CoV-2 variant B.1.1.7 in the United States. Cell. 2021;184:2595&#x2013;2604. doi: 10.1016/j.cell.2021.03.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.03.061</ArticleId><ArticleId IdType="pmc">PMC8018830</ArticleId><ArticleId IdType="pubmed">33891875</ArticleId></ArticleIdList></Reference><Reference><Citation>Washington N.L., Gangavarapu K., Zeller M., Bolze A., Cirulli E.T., Schiabor Barrett K.M., Larsen B.B., Anderson C., White S., Cassens T., et al. Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States. Cell. 2021;184:2587&#x2013;2594.e7. doi: 10.1016/j.cell.2021.03.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.03.052</ArticleId><ArticleId IdType="pmc">PMC8009040</ArticleId><ArticleId IdType="pubmed">33861950</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramesh S., Govindarajulu M., Parise R.S., Neel L., Shankar T., Patel S., Lowery P., Smith F., Dhanasekaran M., Moore T. Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy. Vaccines. 2021;9:1195. doi: 10.3390/vaccines9101195.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9101195</ArticleId><ArticleId IdType="pmc">PMC8537675</ArticleId><ArticleId IdType="pubmed">34696303</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia T.R.T., Young B.E., Chia P.Y. The Omicron-transformer: Rise of the subvariants in the age of vaccines. Ann. Acad. Med. Singap. 2022;51:712&#x2013;729. doi: 10.47102/annals-acadmedsg.2022294.</Citation><ArticleIdList><ArticleId IdType="doi">10.47102/annals-acadmedsg.2022294</ArticleId><ArticleId IdType="pubmed">36453218</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludvigsson J.F. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;109:1088&#x2013;1095. doi: 10.1111/apa.15270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15270</ArticleId><ArticleId IdType="pmc">PMC7228328</ArticleId><ArticleId IdType="pubmed">32202343</ArticleId></ArticleIdList></Reference><Reference><Citation>Radia T., Williams N., Agrawal P., Harman K., Weale J., Cook J., Gupta A. Multi-system inflammatory syndrome in children &amp; adolescents (MIS-C): A systematic review of clinical features and presentation. Paediatr. Respir. Rev. 2021;38:51&#x2013;57. doi: 10.1016/j.prrv.2020.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prrv.2020.08.001</ArticleId><ArticleId IdType="pmc">PMC7417920</ArticleId><ArticleId IdType="pubmed">32891582</ArticleId></ArticleIdList></Reference><Reference><Citation>Strasser Z.H., Greifer N., Hadavand A., Murphy S.N., Estiri H. Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England. JAMA Netw. Open. 2022;5:e2238354. doi: 10.1001/jamanetworkopen.2022.38354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.38354</ArticleId><ArticleId IdType="pmc">PMC9597387</ArticleId><ArticleId IdType="pubmed">36282501</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardu C., Gambardella J., Morelli M.B., Wang X., Marfella R., Santulli G. Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence. J. Clin. Med. 2020;9:1417. doi: 10.3390/jcm9051417.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9051417</ArticleId><ArticleId IdType="pmc">PMC7290769</ArticleId><ArticleId IdType="pubmed">32403217</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L., Niu Z., Jiang X., Zhang Z., Zheng Y., Wang Z., Zhu Y., Gao L., Huang H., Wang X., et al. SARS-CoV-2 Targets by the pscRNA Profiling of ACE2, TMPRSS2 and Furin Proteases. iScience. 2020;23:101744. doi: 10.1016/j.isci.2020.101744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101744</ArticleId><ArticleId IdType="pmc">PMC7591870</ArticleId><ArticleId IdType="pubmed">33134888</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal H., Das N., Nathani S., Saha S., Saini S., Kakar S.S., Roy P. An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner. Stem Cell Rev. Rep. 2021;17:94&#x2013;112. doi: 10.1007/s12015-020-10048-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-020-10048-z</ArticleId><ArticleId IdType="pmc">PMC7541100</ArticleId><ArticleId IdType="pubmed">33029768</ArticleId></ArticleIdList></Reference><Reference><Citation>Albini A., Di Guardo G., Noonan D.M., Lombardo M. The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: Implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies. Intern. Emerg. Med. 2020;15:759&#x2013;766. doi: 10.1007/s11739-020-02364-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-020-02364-6</ArticleId><ArticleId IdType="pmc">PMC7236433</ArticleId><ArticleId IdType="pubmed">32430651</ArticleId></ArticleIdList></Reference><Reference><Citation>Bornstein S.R., Dalan R., Hopkins D., Mingrone G., Boehm B.O. Endocrine and metabolic link to coronavirus infection. Nat. Rev. Endocrinol. 2020;16:297&#x2013;298. doi: 10.1038/s41574-020-0353-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-020-0353-9</ArticleId><ArticleId IdType="pmc">PMC7113912</ArticleId><ArticleId IdType="pubmed">32242089</ArticleId></ArticleIdList></Reference><Reference><Citation>Domovitz T., Ayoub S., Werbner M., Alter J., Izhaki Tavor L., Yahalom-Ronen Y., Tikhonov E., Meirson T., Maman Y., Paran N., et al. HCV Infection Increases the Expression of ACE2 Receptor, Leading to Enhanced Entry of Both HCV and SARS-CoV-2 into Hepatocytes and a Coinfection State. Microbiol. Spectr. 2022;10:e0115022. doi: 10.1128/spectrum.01150-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.01150-22</ArticleId><ArticleId IdType="pmc">PMC9769977</ArticleId><ArticleId IdType="pubmed">36314945</ArticleId></ArticleIdList></Reference><Reference><Citation>Farshidfar F., Koleini N., Ardehali H. Cardiovascular complications of COVID-19. JCI Insight. 2021;6:e148980. doi: 10.1172/jci.insight.148980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.148980</ArticleId><ArticleId IdType="pmc">PMC8410051</ArticleId><ArticleId IdType="pubmed">34061779</ArticleId></ArticleIdList></Reference><Reference><Citation>Karuppan M.K.M., Devadoss D., Nair M., Chand H.S., Lakshmana M.K. SARS-CoV-2 Infection in the Central and Peripheral Nervous System-Associated Morbidities and Their Potential Mechanism. Mol. Neurobiol. 2021;58:2465&#x2013;2480. doi: 10.1007/s12035-020-02245-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-020-02245-1</ArticleId><ArticleId IdType="pmc">PMC7805264</ArticleId><ArticleId IdType="pubmed">33439437</ArticleId></ArticleIdList></Reference><Reference><Citation>Landecho M.F., Yuste J.R., G&#xe1;ndara E., Sunsundegui P., Quiroga J., Alcaide A.B., Garc&#xed;a-Layana A. COVID-19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease? J. Intern. Med. 2021;289:116&#x2013;120. doi: 10.1111/joim.13156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13156</ArticleId><ArticleId IdType="pubmed">32729633</ArticleId></ArticleIdList></Reference><Reference><Citation>Oster M.E., Shay D.K., Su J.R., Gee J., Creech C.B., Broder K.R., Edwards K., Soslow J.H., Dendy J.M., Schlaudecker E., et al. Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021. JAMA. 2022;327:331&#x2013;340. doi: 10.1001/jama.2021.24110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.24110</ArticleId><ArticleId IdType="pmc">PMC8790664</ArticleId><ArticleId IdType="pubmed">35076665</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng J.H., Liu Y.X., Yuan J., Wang F.X., Wu W.B., Li J.X., Wang L.F., Gao H., Wang Y., Dong C.F., et al. First case of COVID-19 complicated with fulminant myocarditis: A case report and insights. Infection. 2020;48:773&#x2013;777. doi: 10.1007/s15010-020-01424-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-020-01424-5</ArticleId><ArticleId IdType="pmc">PMC7146072</ArticleId><ArticleId IdType="pubmed">32277408</ArticleId></ArticleIdList></Reference><Reference><Citation>Penna C., Mercurio V., Tocchetti C.G., Pagliaro P. Sex-related differences in COVID-19 lethality. Br. J. Pharmacol. 2020;177:4375&#x2013;4385. doi: 10.1111/bph.15207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15207</ArticleId><ArticleId IdType="pmc">PMC7405496</ArticleId><ArticleId IdType="pubmed">32698249</ArticleId></ArticleIdList></Reference><Reference><Citation>Sungnak W., Huang N., B&#xe9;cavin C., Berg M., Queen R., Litvinukova M., Talavera-L&#xf3;pez C., Maatz H., Reichart D., Sampaziotis F., et al. HCA Lung Biological Network. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat. Med. 2020;26:681&#x2013;687. doi: 10.1038/s41591-020-0868-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0868-6</ArticleId><ArticleId IdType="pmc">PMC8637938</ArticleId><ArticleId IdType="pubmed">32327758</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss S.R., Leibowitz J.L. Coronavirus pathogenesis. Adv. Virus Res. 2011;81:85&#x2013;164. doi: 10.1016/b978-0-12-385885-6.00009-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/b978-0-12-385885-6.00009-2</ArticleId><ArticleId IdType="pmc">PMC7149603</ArticleId><ArticleId IdType="pubmed">22094080</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou L., Ruan F., Huang M., Liang L., Huang H., Hong Z., Yu J., Kang M., Song Y., Xia J., et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N. Engl. J. Med. 2020;382:1177&#x2013;1179. doi: 10.1056/NEJMc2001737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2001737</ArticleId><ArticleId IdType="pmc">PMC7121626</ArticleId><ArticleId IdType="pubmed">32074444</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta M.K., Vemula S., Donde R., Gouda G., Behera L., Vadde R. In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel. J. Biomol. Struct. Dyn. 2021;39:2617&#x2013;2627. doi: 10.1080/07391102.2020.1751300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07391102.2020.1751300</ArticleId><ArticleId IdType="pmc">PMC7171389</ArticleId><ArticleId IdType="pubmed">32238078</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou H., Yang Y., Dai H., Xiong Y., Wang J.Q., Lin L., Chen Z.S. Recent Updates in Experimental Research and Clinical Evaluation on Drugs for COVID-19 Treatment. Front. Pharmacol. 2021;12:732403. doi: 10.3389/fphar.2021.732403.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.732403</ArticleId><ArticleId IdType="pmc">PMC8646041</ArticleId><ArticleId IdType="pubmed">34880750</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan Q., Yang K., Wang W., Jiang L., Song J. Correction to: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46:1294&#x2013;1297. doi: 10.1007/s00134-020-06028-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06028-z</ArticleId><ArticleId IdType="pmc">PMC7131986</ArticleId><ArticleId IdType="pubmed">32253449</ArticleId></ArticleIdList></Reference><Reference><Citation>Azevedo R.B., Botelho B.G., Hollanda J.V.G., Ferreira L.V.L., Junqueira de Andrade L.Z., Oei S., Mello T.S., Muxfeldt E.S. COVID-19 and the cardiovascular system: A comprehensive review. J. Hum. Hypertens. 2021;35:4&#x2013;11. doi: 10.1038/s41371-020-0387-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41371-020-0387-4</ArticleId><ArticleId IdType="pmc">PMC7384729</ArticleId><ArticleId IdType="pubmed">32719447</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawakami R., Sakamoto A., Kawai K., Gianatti A., Pellegrini D., Nasr A., Kutys B., Guo L., Cornelissen A., Mori M., et al. Pathological Evidence for SARS-CoV-2 as a Cause of Myocarditis: JACC Review Topic of the Week. J. Am. Coll. Cardiol. 2021;77:314&#x2013;325. doi: 10.1016/j.jacc.2020.11.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.11.031</ArticleId><ArticleId IdType="pmc">PMC7816957</ArticleId><ArticleId IdType="pubmed">33478655</ArticleId></ArticleIdList></Reference><Reference><Citation>Pepera G., Tribali M.S., Batalik L., Petrov I., Papathanasiou J. Epidemiology, risk factors and prognosis of cardiovascular disease in the Coronavirus Disease 2019 (COVID-19) pandemic era: A systematic review. Rev. Cardiovasc. Med. 2022;23:28. doi: 10.31083/j.rcm2301028.</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.rcm2301028</ArticleId><ArticleId IdType="pubmed">35092220</ArticleId></ArticleIdList></Reference><Reference><Citation>Hessami A., Shamshirian A., Heydari K., Pourali F., Alizadeh-Navaei R., Moosazadeh M., Abrotan S., Shojaie L., Sedighi S., Shamshirian D., et al. Cardiovascular diseases burden in COVID-19: Systematic review and meta-analysis. Am. J. Emerg. Med. 2021;46:382&#x2013;391. doi: 10.1016/j.ajem.2020.10.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2020.10.022</ArticleId><ArticleId IdType="pmc">PMC7561581</ArticleId><ArticleId IdType="pubmed">33268238</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., McGoogan J.M. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239&#x2013;1242. doi: 10.1001/jama.2020.2648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Eltriki M., Hopefl R., Wright J.M., Deb S. Association between Vitamin D Status and Risk of Developing Severe COVID-19 Infection: A Meta-Analysis of Observational Studies. J. Am. Nutr. Assoc. 2022;41:679&#x2013;689. doi: 10.1080/07315724.2021.1951891.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07315724.2021.1951891</ArticleId><ArticleId IdType="pmc">PMC8425440</ArticleId><ArticleId IdType="pubmed">34464543</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim C.W., Aronow W.S. COVID-19, cardiovascular diseases and cardiac troponins. Future Cardiol. 2022;18:135&#x2013;142. doi: 10.2217/fca-2021-0054.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fca-2021-0054</ArticleId><ArticleId IdType="pmc">PMC8438926</ArticleId><ArticleId IdType="pubmed">34476978</ArticleId></ArticleIdList></Reference><Reference><Citation>Sar&#x131;&#xe7;am E., Dursun A.D., T&#xfc;rkmen Sar&#x131;y&#x131;ld&#x131;z G., Can N., Bozkurt E., G&#xf6;n&#xfc;ll&#xfc; U., Basay N., T&#xfc;rkmen M., Denli A., &#xdc;nl&#xfc; M. Laboratory and Imaging Evaluation of Cardiac Involvement in Patients with Post-Acute COVID-19. Int. J. Gen. Med. 2021;14:4977&#x2013;4985. doi: 10.2147/IJGM.S321156.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S321156</ArticleId><ArticleId IdType="pmc">PMC8412825</ArticleId><ArticleId IdType="pubmed">34511982</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmid A., Petrovic M., Akella K., Pareddy A., Velavan S.S. Getting to the Heart of the Matter: Myocardial Injury, Coagulopathy, and Other Potential Cardiovascular Implications of COVID-19. Int. J. Vasc. Med. 2021;2021:6693895. doi: 10.1155/2021/6693895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/6693895</ArticleId><ArticleId IdType="pmc">PMC8118745</ArticleId><ArticleId IdType="pubmed">34035963</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S., Qin M., Shen B., Cai Y., Liu T., Yang F., Gong W., Liu X., Liang J., Zhao Q., et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802&#x2013;810. doi: 10.1001/jamacardio.2020.0950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.0950</ArticleId><ArticleId IdType="pmc">PMC7097841</ArticleId><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker C., Deb S., Ling H., Wang Z. Assessing the Elevation of Cardiac Biomarkers and the Severity of COVID-19 Infection: A Meta-Analysis. J. Pharm. Pharm. Sci. 2020;23:396&#x2013;405. doi: 10.18433/jpps31501.</Citation><ArticleIdList><ArticleId IdType="doi">10.18433/jpps31501</ArticleId><ArticleId IdType="pubmed">33086028</ArticleId></ArticleIdList></Reference><Reference><Citation>Bavishi C., Bonow R.O., Trivedi V., Abbott J.D., Messerli F.H., Bhatt D.L. Special Article&#x2014;Acute myocardial injury in patients hospitalized with COVID-19 infection: A review. Prog. Cardiovasc. Dis. 2020;63:682&#x2013;689. doi: 10.1016/j.pcad.2020.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcad.2020.05.013</ArticleId><ArticleId IdType="pmc">PMC7274977</ArticleId><ArticleId IdType="pubmed">32512122</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou J., Thomas P.G., Randolph A.G. Immunology of SARS-CoV-2 infection in children. Nat. Immunol. 2022;23:177&#x2013;185. doi: 10.1038/s41590-021-01123-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01123-9</ArticleId><ArticleId IdType="pmc">PMC8981222</ArticleId><ArticleId IdType="pubmed">35105983</ArticleId></ArticleIdList></Reference><Reference><Citation>de Cevins C., Luka M., Smith N., Meynier S., Mag&#xe9;rus A., Carbone F., Garc&#xed;a-Paredes V., Barnabei L., Batignes M., Boull&#xe9; A., et al. A monocyte/dendritic cell molecular signature of SARS-CoV-2-related multisystem inflammatory syndrome in children with severe myocarditis. Med. 2021;2:1072&#x2013;1092.e7. doi: 10.1016/j.medj.2021.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2021.08.002</ArticleId><ArticleId IdType="pmc">PMC8363470</ArticleId><ArticleId IdType="pubmed">34414385</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson L.A., Canna S.W., Friedman K.G., Gorelik M., Lapidus S.K., Bassiri H., Behrens E.M., Kernan K.F., Schulert G.S., Seo P., et al. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 3. Arthritis Rheumatol. 2022;74:e1&#x2013;e20. doi: 10.1002/art.42062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.42062</ArticleId><ArticleId IdType="pmc">PMC9011620</ArticleId><ArticleId IdType="pubmed">35118829</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste L., Van Paemel R., Haerynck F. Multisystem inflammatory syndrome in children related to COVID-19: A systematic review. Eur. J. Pediatr. 2021;180:2019&#x2013;2034. doi: 10.1007/s00431-021-03993-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-03993-5</ArticleId><ArticleId IdType="pmc">PMC7890544</ArticleId><ArticleId IdType="pubmed">33599835</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel J.M. Multisystem Inflammatory Syndrome in Children (MIS-C) Curr. Allergy Asthma Rep. 2022;22:53&#x2013;60. doi: 10.1007/s11882-022-01031-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11882-022-01031-4</ArticleId><ArticleId IdType="pmc">PMC8938222</ArticleId><ArticleId IdType="pubmed">35314921</ArticleId></ArticleIdList></Reference><Reference><Citation>Sperotto F., Friedman K.G., Son M.B.F., VanderPluym C.J., Newburger J.W., Dionne A. Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: A comprehensive review and proposed clinical approach. Eur. J. Pediatr. 2021;180:307&#x2013;322. doi: 10.1007/s00431-020-03766-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-020-03766-6</ArticleId><ArticleId IdType="pmc">PMC7429125</ArticleId><ArticleId IdType="pubmed">32803422</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogel T.P., Top K.A., Karatzios C., Hilmers D.C., Tapia L.I., Moceri P., Giovannini-Chami L., Wood N., Chandler R.E., Klein N.P., et al. Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition &amp; guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2021;39:3037&#x2013;3049. doi: 10.1016/j.vaccine.2021.01.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2021.01.054</ArticleId><ArticleId IdType="pmc">PMC7904456</ArticleId><ArticleId IdType="pubmed">33640145</ArticleId></ArticleIdList></Reference><Reference><Citation>Waseem M., Shariff M.A., Tay E.T., Mortel D., Savadkar S., Lee H., Kondamudi N., Liang T. Multisystem Inflammatory Syndrome in Children. J. Emerg. Med. 2022;62:28&#x2013;37. doi: 10.1016/j.jemermed.2021.07.070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jemermed.2021.07.070</ArticleId><ArticleId IdType="pmc">PMC8445772</ArticleId><ArticleId IdType="pubmed">34538678</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C., Chen X., Cai Y., Xia J., Zhou X., Xu S., Huang H., Zhang L., Zhou X., Du C., et al. Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern. Med. 2020;180:934&#x2013;943. doi: 10.1001/jamainternmed.2020.0994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.0994</ArticleId><ArticleId IdType="pmc">PMC7070509</ArticleId><ArticleId IdType="pubmed">32167524</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma C., Ganigara M., Galeotti C., Burns J., Berganza F.M., Hayes D.A., Singh-Grewal D., Bharath S., Sajjan S., Bayry J. Multisystem inflammatory syndrome in children and Kawasaki disease: A critical comparison. Nat. Rev. Rheumatol. 2021;17:731&#x2013;748. doi: 10.1038/s41584-021-00709-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-021-00709-9</ArticleId><ArticleId IdType="pmc">PMC8554518</ArticleId><ArticleId IdType="pubmed">34716418</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrizales-Sep&#xfa;lveda E.F., Vera-Pineda R., Flores-Ram&#xed;rez R., Hern&#xe1;ndez-Guajardo D.A., P&#xe9;rez-Contreras E., Lozano-Ibarra M.M., Ordaz-Far&#xed;as A. Echocardiographic Manifestations in COVID-19: A Review. Heart Lung Circ. 2021;30:1117&#x2013;1129. doi: 10.1016/j.hlc.2021.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2021.02.004</ArticleId><ArticleId IdType="pmc">PMC7894123</ArticleId><ArticleId IdType="pubmed">33715970</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain S.S., Liu Q., Raikhelkar J., Fried J., Elias P., Poterucha T.J., DeFilippis E.M., Rosenblum H., Wang E.Y., Redfors B., et al. Indications for and Findings on Transthoracic Echocardiography in COVID-19. J. Am. Soc. Echocardiogr. 2020;33:1278&#x2013;1284. doi: 10.1016/j.echo.2020.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2020.06.009</ArticleId><ArticleId IdType="pmc">PMC7298489</ArticleId><ArticleId IdType="pubmed">32782131</ArticleId></ArticleIdList></Reference><Reference><Citation>St&#xf6;be S., Richter S., Seige M., Stehr S., Laufs U., Hagendorff A. Echocardiographic characteristics of patients with SARS-CoV-2 infection. Clin. Res. Cardiol. 2020;109:1549&#x2013;1566. doi: 10.1007/s00392-020-01727-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-020-01727-5</ArticleId><ArticleId IdType="pmc">PMC7428201</ArticleId><ArticleId IdType="pubmed">32803387</ArticleId></ArticleIdList></Reference><Reference><Citation>Barssoum K., Victor V., Salem A., Kumar A., Mubasher M., Hassib M., Magdi M., Renjithlal S., Abdelazeem M., Shariff M., et al. Echocardiography, lung ultrasound, and cardiac magnetic resonance findings in COVID-19: A systematic review. Echocardiography. 2021;38:1365&#x2013;1404. doi: 10.1111/echo.15152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/echo.15152</ArticleId><ArticleId IdType="pmc">PMC8444724</ArticleId><ArticleId IdType="pubmed">34236091</ArticleId></ArticleIdList></Reference><Reference><Citation>Szekely Y., Lichter Y., Taieb P., Banai A., Hochstadt A., Merdler I., Gal Oz A., Rothschild E., Baruch G., Peri Y., et al. Spectrum of Cardiac Manifestations in COVID-19: A Systematic Echocardiographic Study. Circulation. 2020;142:342&#x2013;353. doi: 10.1161/CIRCULATIONAHA.120.047971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047971</ArticleId><ArticleId IdType="pmc">PMC7382541</ArticleId><ArticleId IdType="pubmed">32469253</ArticleId></ArticleIdList></Reference><Reference><Citation>Baycan O.F., Barman H.A., Atici A., Tatlisu A., Bolen F., Ergen P., Icten S., Gungor B., Caliskan M. Evaluation of biventricular function in patients with COVID-19 using speckle tracking echocardiography. Int. J. Cardiovasc. Imaging. 2021;37:135&#x2013;144. doi: 10.1007/s10554-020-01968-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10554-020-01968-5</ArticleId><ArticleId IdType="pmc">PMC7429089</ArticleId><ArticleId IdType="pubmed">32803484</ArticleId></ArticleIdList></Reference><Reference><Citation>Smolgovsky S., Ibeh U., Tamayo T.P., Alcaide P. Adding insult to injury&#x2014;Inflammation at the heart of cardiac fibrosis. Cell. Signal. 2021;77:109828. doi: 10.1016/j.cellsig.2020.109828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2020.109828</ArticleId><ArticleId IdType="pmc">PMC7718304</ArticleId><ArticleId IdType="pubmed">33166625</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M., Verleden S.E., Kuehnel M., Haverich A., Welte T., Laenger F., Vanstapel A., Werlein C., Stark H., Tzankov A., et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in COVID-19. N. Engl. J. Med. 2020;383:120&#x2013;128. doi: 10.1056/NEJMoa2015432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I., Timens W., Bulthuis M.L., Lely A.T., Navis G., van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 2004;203:631&#x2013;637. doi: 10.1002/path.1570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1570</ArticleId><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Lovren F., Pan Y., Quan A., Teoh H., Wang G., Shukla P.C., Levitt K.S., Oudit G.Y., Al-Omran M., Stewart D.J., et al. Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis. Am. J. Physiol. Heart Circ. Physiol. 2008;295:H1377&#x2013;H1384. doi: 10.1152/ajpheart.00331.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00331.2008</ArticleId><ArticleId IdType="pubmed">18660448</ArticleId></ArticleIdList></Reference><Reference><Citation>Muus C., Luecken M.D., Eraslan G., Sikkema L., Waghray A., Heimberg G., Kobayashi Y., Vaishnav E.D., Subramanian A., Smillie C., et al. Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics. Nat. Med. 2021;27:546&#x2013;559. doi: 10.1038/s41591-020-01227-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-01227-z</ArticleId><ArticleId IdType="pmc">PMC9469728</ArticleId><ArticleId IdType="pubmed">33654293</ArticleId></ArticleIdList></Reference><Reference><Citation>Sluimer J.C., Gasc J.M., Hamming I., van Goor H., Michaud A., van den Akker L.H., J&#xfc;tten B., Cleutjens J., Bijnens A.P., Corvol P., et al. Angiotensin-converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesions. J. Pathol. 2008;215:273&#x2013;279. doi: 10.1002/path.2357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.2357</ArticleId><ArticleId IdType="pubmed">18498093</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z., Flammer A.J., Steiger P., Haberecker M., Andermatt R., Zinkernagel A.S., Mehra M.R., Schuepbach R.A., Ruschitzka F., Moch H. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417&#x2013;1418. doi: 10.1016/s0140-6736(20)30937-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z., Mateus J., Coelho C.H., Dan J.M., Moderbacher C.R., G&#xe1;lvez R.I., Cortes F.H., Grifoni A., Tarke A., Chang J., et al. Humoral and cellular immune memory to four COVID-19 vaccines. Cell. 2022;185:2434&#x2013;2451.e17. doi: 10.1016/j.cell.2022.05.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.05.022</ArticleId><ArticleId IdType="pmc">PMC9135677</ArticleId><ArticleId IdType="pubmed">35764089</ArticleId></ArticleIdList></Reference><Reference><Citation>Muhl L., He L., Sun Y., Andaloussi M&#xe4;e M., Pietil&#xe4; R., Liu J., Genov&#xe9; G., Zhang L., Xie Y., Leptidis S., et al. The SARS-CoV-2 receptor ACE2 is expressed in mouse pericytes but not endothelial cells: Implications for COVID-19 vascular research. Stem Cell Rep. 2022;17:1089&#x2013;1104. doi: 10.1016/j.stemcr.2022.03.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2022.03.016</ArticleId><ArticleId IdType="pmc">PMC9022216</ArticleId><ArticleId IdType="pubmed">35452595</ArticleId></ArticleIdList></Reference><Reference><Citation>Smadja D.M., Mentzer S.J., Fontenay M., Laffan M.A., Ackermann M., Helms J., Jonigk D., Chocron R., Pier G.B., Gendron N., et al. COVID-19 is a systemic vascular hemopathy: Insight for mechanistic and clinical aspects. Angiogenesis. 2021;24:755&#x2013;788. doi: 10.1007/s10456-021-09805-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-021-09805-6</ArticleId><ArticleId IdType="pmc">PMC8238037</ArticleId><ArticleId IdType="pubmed">34184164</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu H., Wen Z., Li N., Zhang Z., Ceesay B.M., Peng Y., Zhou N., Wang D.W. COVID-19 and Cardiovascular Diseases: From Cellular Mechanisms to Clinical Manifestations. Aging Dis. 2023;14:2071&#x2013;2088. doi: 10.14336/AD.2023.0314.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2023.0314</ArticleId><ArticleId IdType="pmc">PMC10676802</ArticleId><ArticleId IdType="pubmed">37199573</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y.Y., Ma Y.T., Zhang J.Y., Xie X. COVID-19 and the cardiovascular system. Nat. Rev. Cardiol. 2020;17:259&#x2013;260. doi: 10.1038/s41569-020-0360-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-0360-5</ArticleId><ArticleId IdType="pmc">PMC7095524</ArticleId><ArticleId IdType="pubmed">32139904</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoyagi T., Sato Y., Baba H., Shiga T., Seike I., Niitsuma Sugaya I., Takei K., Iwasaki Y., Oshima K., Kanamori H., et al. Case Report: Successful Treatment of Five Critically Ill Coronavirus Disease 2019 Patients Using Combination Therapy With Etoposide and Corticosteroids. Front. Med. 2021;8:718641. doi: 10.3389/fmed.2021.718641.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.718641</ArticleId><ArticleId IdType="pmc">PMC8496678</ArticleId><ArticleId IdType="pubmed">34631741</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng B., Ma J., Yang Y., Shao T., Zhao B., Zeng L. Systemic Corticosteroid Administration in Coronavirus Disease 2019 Outcomes: An Umbrella Meta-Analysis Incorporating Both Mild and Pulmonary Fibrosis-Manifested Severe Disease. Front. Pharmacol. 2021;12:670170. doi: 10.3389/fphar.2021.670170.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.670170</ArticleId><ArticleId IdType="pmc">PMC8187793</ArticleId><ArticleId IdType="pubmed">34122093</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubio-Rivas M., Ronda M., Padulles A., Mitjavila F., Riera-Mestre A., Garc&#xed;a-Forero C., Iriarte A., Mora J.M., Padulles N., Gonzalez M., et al. Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness. Int. J. Infect. Dis. 2020;101:290&#x2013;297. doi: 10.1016/j.ijid.2020.09.1486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.09.1486</ArticleId><ArticleId IdType="pmc">PMC7537652</ArticleId><ArticleId IdType="pubmed">33035673</ArticleId></ArticleIdList></Reference><Reference><Citation>Pantos C., Kostopanagiotou G., Armaganidis A., Trikas A., Tseti I., Mourouzis I. Triiodothyronine for the treatment of critically ill patients with COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020;21:573. doi: 10.1186/s13063-020-04474-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-020-04474-0</ArticleId><ArticleId IdType="pmc">PMC7316579</ArticleId><ArticleId IdType="pubmed">32586399</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne J.A.C., Murthy S., Diaz J.V., Slutsky A.S., Villar J., Angus D.C., Annane D., Azevedo L.C.P., Berwanger O., Cavalcanti A.B., et al. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. JAMA. 2020;324:1330&#x2013;1341. doi: 10.1001/jama.2020.17023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.17023</ArticleId><ArticleId IdType="pmc">PMC7489434</ArticleId><ArticleId IdType="pubmed">32876694</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . Corticosteroids for COVID-19: Living Guidance. WHO; Geneva, Switzerland: 2020.</Citation></Reference><Reference><Citation>Langford B.J., So M., Raybardhan S., Leung V., Soucy J.R., Westwood D., Daneman N., MacFadden D.R. Antibiotic prescribing in patients with COVID-19: Rapid review and meta-analysis. Clin. Microbiol. Infect. 2021;27:520&#x2013;531. doi: 10.1016/j.cmi.2020.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.12.018</ArticleId><ArticleId IdType="pmc">PMC7785281</ArticleId><ArticleId IdType="pubmed">33418017</ArticleId></ArticleIdList></Reference><Reference><Citation>Langford B.J., So M., Raybardhan S., Leung V., Westwood D., MacFadden D.R., Soucy J.R., Daneman N. Bacterial co-infection and secondary infection in patients with COVID-19: A living rapid review and meta-analysis. Clin. Microbiol. Infect. 2020;26:1622&#x2013;1629. doi: 10.1016/j.cmi.2020.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.07.016</ArticleId><ArticleId IdType="pmc">PMC7832079</ArticleId><ArticleId IdType="pubmed">32711058</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens R.W., Jensen K., Kooda K., Mara K., O&#x2019;Horo J.C., Shah A. A retrospective antibiotic prescribing assessment and examination of potential antibiotic stewardship targets in patients with COVID-19. JAC Antimicrob. Resist. 2021;3:dlab170. doi: 10.1093/jacamr/dlab170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jacamr/dlab170</ArticleId><ArticleId IdType="pmc">PMC8569441</ArticleId><ArticleId IdType="pubmed">34755114</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J., Tacquard C., Severac F., Leonard-Lorant I., Ohana M., Delabranche X., Merdji H., Clere-Jehl R., Schenck M., Fagot Gandet F., et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: A multicenter prospective cohort study. Intensive Care Med. 2020;46:1089&#x2013;1098. doi: 10.1007/s00134-020-06062-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06062-x</ArticleId><ArticleId IdType="pmc">PMC7197634</ArticleId><ArticleId IdType="pubmed">32367170</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw R.J., Bradbury C., Abrams S.T., Wang G., Toh C.H. COVID-19 and immunothrombosis: Emerging understanding and clinical management. Br. J. Haematol. 2021;194:518&#x2013;529. doi: 10.1111/bjh.17664.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.17664</ArticleId><ArticleId IdType="pubmed">34114204</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomerak S., Khan S., Almasri M., Hussein R., Abdelati A., Aly A., Salameh M.A., Saed Aldien A., Naveed H., Elshazly M.B., et al. Systemic inflammation in COVID-19 patients may induce various types of venous and arterial thrombosis: A systematic review. Scand. J. Immunol. 2021;94:e13097. doi: 10.1111/sji.13097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sji.13097</ArticleId><ArticleId IdType="pmc">PMC8646950</ArticleId><ArticleId IdType="pubmed">34940978</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes G.D., Burnett A., Allen A., Blumenstein M., Clark N.P., Cuker A., Dager W.E., Deitelzweig S.B., Ellsworth S., Garcia D., et al. Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: Interim clinical guidance from the anticoagulation forum. J. Thromb. Thrombolysis. 2020;50:72&#x2013;81. doi: 10.1007/s11239-020-02138-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-020-02138-z</ArticleId><ArticleId IdType="pmc">PMC9111941</ArticleId><ArticleId IdType="pubmed">35579732</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf8;lhave M., Agergaard J., Wejse C. Clinical Management of COVID-19 Patients&#x2014;An Update. Semin. Nucl. Med. 2022;52:4&#x2013;10. doi: 10.1053/j.semnuclmed.2021.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.semnuclmed.2021.06.004</ArticleId><ArticleId IdType="pmc">PMC8206588</ArticleId><ArticleId IdType="pubmed">34243904</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletto F., Spiezia L., Simion C., Campello E., Dalla Valle F., Tormene D., Camporese G., Simioni P. Risk Factors of Venous Thromboembolism in Noncritically Ill Patients Hospitalized for Acute COVID-19 Pneumonia Receiving Prophylactic-Dose Anticoagulation. Viruses. 2022;14:737. doi: 10.3390/v14040737.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14040737</ArticleId><ArticleId IdType="pmc">PMC9025628</ArticleId><ArticleId IdType="pubmed">35458467</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC . Centers for Disease Control and Prevention. CDC; Atlanta, GA, USA: 2020.</Citation></Reference><Reference><Citation>Chen W., Liang B., Wu X., Li L., Wang C., Xing D. Advances and challenges in using nirmatrelvir and its derivatives against SARS-CoV-2 infection. J. Pharm. Anal. 2023;13:255&#x2013;261. doi: 10.1016/j.jpha.2022.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpha.2022.10.005</ArticleId><ArticleId IdType="pmc">PMC9628234</ArticleId><ArticleId IdType="pubmed">36345404</ArticleId></ArticleIdList></Reference><Reference><Citation>Sendi P., Razonable R.R., Nelson S.B., Soriano A., Gandhi R.T. First-generation oral antivirals against SARS-CoV-2. Clin. Microbiol. Infect. 2022;28:1230&#x2013;1235. doi: 10.1016/j.cmi.2022.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.04.015</ArticleId><ArticleId IdType="pmc">PMC9080050</ArticleId><ArticleId IdType="pubmed">35545195</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefan N., Birkenfeld A.L., Schulze M.B. Global pandemics interconnected&#x2014;Obesity, impaired metabolic health and COVID-19. Nat. Rev. Endocrinol. 2021;17:135&#x2013;149. doi: 10.1038/s41574-020-00462-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-020-00462-1</ArticleId><ArticleId IdType="pubmed">33479538</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Chi J., Lv W., Wang Y. Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (COVID-19) Diabetes Metab. Res. Rev. 2021;37:e3377. doi: 10.1002/dmrr.3377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dmrr.3377</ArticleId><ArticleId IdType="pmc">PMC7361201</ArticleId><ArticleId IdType="pubmed">32588943</ArticleId></ArticleIdList></Reference><Reference><Citation>Gokce N., Vita J.A., Bader D.S., Sherman D.L., Hunter L.M., Holbrook M., O&#x2019;Malley C., Keaney J.F., Jr., Balady G.J. Effect of exercise on upper and lower extremity endothelial function in patients with coronary artery disease. Am. J. Cardiol. 2002;90:124&#x2013;127. doi: 10.1016/S0002-9149(02)02433-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9149(02)02433-5</ArticleId><ArticleId IdType="pubmed">12106840</ArticleId></ArticleIdList></Reference><Reference><Citation>Hambrecht R., Wolf A., Gielen S., Linke A., Hofer J., Erbs S., Schoene N., Schuler G. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N. Engl. J. Med. 2000;342:454&#x2013;460. doi: 10.1056/NEJM200002173420702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200002173420702</ArticleId><ArticleId IdType="pubmed">10675425</ArticleId></ArticleIdList></Reference><Reference><Citation>Powell R., McGregor G., Ennis S., Kimani P.K., Underwood M. Is exercise-based cardiac rehabilitation effective? A systematic review and meta-analysis to re-examine the evidence. BMJ Open. 2018;8:e019656. doi: 10.1136/bmjopen-2017-019656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-019656</ArticleId><ArticleId IdType="pmc">PMC5857699</ArticleId><ArticleId IdType="pubmed">29540415</ArticleId></ArticleIdList></Reference><Reference><Citation>Tregoning J.S., Flight K.E., Higham S.L., Wang Z., Pierce B.F. Progress of the COVID-19 vaccine effort: Viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat. Rev. Immunol. 2021;21:626&#x2013;636. doi: 10.1038/s41577-021-00592-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00592-1</ArticleId><ArticleId IdType="pmc">PMC8351583</ArticleId><ArticleId IdType="pubmed">34373623</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson O.J., Barnsley G., Toor J., Hogan A.B., Winskill P., Ghani A.C. Global impact of the first year of COVID-19 vaccination: A mathematical modelling study. Lancet Infect. Dis. 2022;22:1293&#x2013;1302. doi: 10.1016/S1473-3099(22)00320-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00320-6</ArticleId><ArticleId IdType="pmc">PMC9225255</ArticleId><ArticleId IdType="pubmed">35753318</ArticleId></ArticleIdList></Reference><Reference><Citation>Barouch D.H. COVID-19 Vaccines&#x2014;Immunity, Variants, Boosters. N. Engl. J. Med. 2022;387:1011&#x2013;1020. doi: 10.1056/NEJMra2206573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2206573</ArticleId><ArticleId IdType="pmc">PMC9454645</ArticleId><ArticleId IdType="pubmed">36044620</ArticleId></ArticleIdList></Reference><Reference><Citation>Chavda V.P., Bezbaruah R., Valu D., Patel B., Kumar A., Prasad S., Kakoti B.B., Kaushik A., Jesawadawala M. Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status. Vaccines. 2023;11:432. doi: 10.3390/vaccines11020432.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11020432</ArticleId><ArticleId IdType="pmc">PMC9965371</ArticleId><ArticleId IdType="pubmed">36851309</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Gars M., Hendriks J., Sadoff J., Ryser M., Struyf F., Douoguih M., Schuitemaker H. Immunogenicity and efficacy of Ad26.COV2.S: An adenoviral vector-based COVID-19 vaccine. Immunol. Rev. 2022;310:47&#x2013;60. doi: 10.1111/imr.13088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.13088</ArticleId><ArticleId IdType="pmc">PMC9349621</ArticleId><ArticleId IdType="pubmed">35689434</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanaparthy R., Mohan G., Vasireddy D., Atluri P. Review of COVID-19 viral vector-based vaccines and COVID-19 variants. Infez. Med. 2021;29:328&#x2013;338. doi: 10.53854/liim-2903-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.53854/liim-2903-3</ArticleId><ArticleId IdType="pmc">PMC8805485</ArticleId><ArticleId IdType="pubmed">35146337</ArticleId></ArticleIdList></Reference><Reference><Citation>Baden L.R., El Sahly H.M., Essink B., Kotloff K., Frey S., Novak R., Diemert D., Spector S.A., Rouphael N., Creech C.B., et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N. Engl. J. Med. 2021;384:403&#x2013;416. doi: 10.1056/NEJMoa2035389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2035389</ArticleId><ArticleId IdType="pmc">PMC7787219</ArticleId><ArticleId IdType="pubmed">33378609</ArticleId></ArticleIdList></Reference><Reference><Citation>Polack F.P., Thomas S.J., Kitchin N., Absalon J., Gurtman A., Lockhart S., Perez J.L., P&#xe9;rez Marc G., Moreira E.D., Zerbini C., et al. Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine. N. Engl. J. Med. 2020;383:2603&#x2013;2615. doi: 10.1056/NEJMoa2034577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2034577</ArticleId><ArticleId IdType="pmc">PMC7745181</ArticleId><ArticleId IdType="pubmed">33301246</ArticleId></ArticleIdList></Reference><Reference><Citation>Barouch D.H., Stephenson K.E., Sadoff J., Yu J., Chang A., Gebre M., McMahan K., Liu J., Chandrashekar A., Patel S., et al. Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination. N. Engl. J. Med. 2021;385:951&#x2013;953. doi: 10.1056/NEJMc2108829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2108829</ArticleId><ArticleId IdType="pmc">PMC8314733</ArticleId><ArticleId IdType="pubmed">34260834</ArticleId></ArticleIdList></Reference><Reference><Citation>Collier A.Y., Yu J., McMahan K., Liu J., Chandrashekar A., Maron J.S., Atyeo C., Martinez D.R., Ansel J.L., Aguayo R., et al. Differential Kinetics of Immune Responses Elicited by COVID-19 Vaccines. N. Engl. J. Med. 2021;385:2010&#x2013;2012. doi: 10.1056/NEJMc2115596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2115596</ArticleId><ArticleId IdType="pmc">PMC8531985</ArticleId><ArticleId IdType="pubmed">34648703</ArticleId></ArticleIdList></Reference><Reference><Citation>Polinski J.M., Weckstein A.R., Batech M., Kabelac C., Kamath T., Harvey R., Jain S., Rassen J.A., Khan N., Schneeweiss S. Durability of the Single-Dose Ad26.COV2.S Vaccine in the Prevention of COVID-19 Infections and Hospitalizations in the US before and during the Delta Variant Surge. JAMA Netw. Open. 2022;5:e222959. doi: 10.1001/jamanetworkopen.2022.2959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.2959</ArticleId><ArticleId IdType="pmc">PMC8931562</ArticleId><ArticleId IdType="pubmed">35297969</ArticleId></ArticleIdList></Reference><Reference><Citation>Gharpure R., Sami S., Vostok J., Johnson H., Hall N., Foreman A., Sabo R.T., Schubert P.L., Shephard H., Brown V.R., et al. Multistate Outbreak of SARS-CoV-2 Infections, Including Vaccine Breakthrough Infections, Associated with Large Public Gatherings, United States. Emerg. Infect. Dis. 2022;28:35&#x2013;43. doi: 10.3201/eid2801.212220.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2801.212220</ArticleId><ArticleId IdType="pmc">PMC8714214</ArticleId><ArticleId IdType="pubmed">34793690</ArticleId></ArticleIdList></Reference><Reference><Citation>Bengtsson E., Lundstrom R. Postvaccinal myocarditis. Cardiologia. 1957;30:1&#x2013;8. doi: 10.1159/000165631.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000165631</ArticleId><ArticleId IdType="pubmed">13396712</ArticleId></ArticleIdList></Reference><Reference><Citation>Feery B.J. Adverse reactions after smallpox vaccination. Med. J. Aust. 1977;2:180&#x2013;183. doi: 10.5694/j.1326-5377.1977.tb114544.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.5694/j.1326-5377.1977.tb114544.x</ArticleId><ArticleId IdType="pubmed">20557</ArticleId></ArticleIdList></Reference><Reference><Citation>Halsell J.S., Riddle J.R., Atwood J.E., Gardner P., Shope R., Poland G.A., Gray G.C., Ostroff S., Eckart R.E., Hospenthal D.R., et al. Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel. JAMA. 2003;289:3283&#x2013;3289. doi: 10.1001/jama.289.24.3283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.289.24.3283</ArticleId><ArticleId IdType="pubmed">12824210</ArticleId></ArticleIdList></Reference><Reference><Citation>Salah H.M., Mehta J.L. COVID-19 Vaccine and Myocarditis. Am. J. Cardiol. 2021;157:146&#x2013;148. doi: 10.1016/j.amjcard.2021.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2021.07.009</ArticleId><ArticleId IdType="pmc">PMC8272967</ArticleId><ArticleId IdType="pubmed">34399967</ArticleId></ArticleIdList></Reference><Reference><Citation>Haas E.J., Angulo F.J., McLaughlin J.M., Anis E., Singer S.R., Khan F., Brooks N., Smaja M., Mircus G., Pan K., et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: An observational study using national surveillance data. Lancet. 2021;397:1819&#x2013;1829. doi: 10.1016/S0140-6736(21)00947-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00947-8</ArticleId><ArticleId IdType="pmc">PMC8099315</ArticleId><ArticleId IdType="pubmed">33964222</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez Bernal J., Andrews N., Gower C., Robertson C., Stowe J., Tessier E., Simmons R., Cottrell S., Roberts R., O&#x2019;Doherty M., et al. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on COVID-19 related symptoms, hospital admissions, and mortality in older adults in England: Test negative case-control study. BMJ. 2021;373:n1088. doi: 10.1136/bmj.n1088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1088</ArticleId><ArticleId IdType="pmc">PMC8116636</ArticleId><ArticleId IdType="pubmed">33985964</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv G., Yuan J., Xiong X., Li M. Mortality Rate and Characteristics of Deaths Following COVID-19 Vaccination. Front. Med. 2021;8:670370. doi: 10.3389/fmed.2021.670370.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.670370</ArticleId><ArticleId IdType="pmc">PMC8160119</ArticleId><ArticleId IdType="pubmed">34055843</ArticleId></ArticleIdList></Reference><Reference><Citation>Faghy M.A., Owen R., Thomas C., Yates J., Ferraro F.V., Skipper L., Barley-McMullen S., Brown D.A., Arena R., Ashton R.E. Is long COVID the next global health crisis? J. Glob. Health. 2022;12:03067. doi: 10.7189/jogh.12.03067.</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.12.03067</ArticleId><ArticleId IdType="pmc">PMC9597397</ArticleId><ArticleId IdType="pubmed">36285549</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Long COVID Collaborators Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328:1604&#x2013;1615. doi: 10.1001/jama.2022.18931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashton R.E., Philips B.E., Faghy M. The acute and chronic implications of the COVID-19 virus on the cardiovascular system in adults: A systematic review. Prog. Cardiovasc. Dis. 2023;76:31&#x2013;37. doi: 10.1016/j.pcad.2023.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcad.2023.01.003</ArticleId><ArticleId IdType="pmc">PMC9854143</ArticleId><ArticleId IdType="pubmed">36690284</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Carerj M.L., Wieters I., Fahim M., Arendt C., Hoffmann J., Shchendrygina A., Escher F., Vasa-Nicotera M., Zeiher A.M., et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265&#x2013;1273. doi: 10.1001/jamacardio.2020.3557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D., Beetler D.J., Di Florio D.N., Musigk N., Heidecker B., Cooper L.T., Jr. COVID-19, Myocarditis and Pericarditis. Circ. Res. 2023;132:1302&#x2013;1319. doi: 10.1161/CIRCRESAHA.123.321878.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.123.321878</ArticleId><ArticleId IdType="pmc">PMC10171304</ArticleId><ArticleId IdType="pubmed">37167363</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>